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Objective: The objective of this study was to estimate the association of vaginal sacrospinous ligament
ﬁxation with anterior-transobturator mesh repair surgery for advanced pelvic organ prolapse in patients
of two different age groups.
Materials and methods: Vaginal sacrospinous ligament ﬁxation with anterior mesh repair as primary
prolapse surgery was performed on 225 patients with advanced pelvic organ prolapse (POP-Q  stage
III). POP-Q < stage II was objective cure and subjective cure was determined according to feedback of
POPDI-6 (Questions 2 and 3). Patients provided responses to UDI-6, IIQ-7, POPDI-6, and PISQ-12 pre- and
postsurgery. Outcome measures were observed in cohorts of two age groups (<75 years and 75 years).
Results: Postoperative data of 217 patients were available. The cumulative objective cure rates were
93.0% and 92.5% for patients aged 75 years and <75 years, respectively, with mean follow-up of
33.93 ± 18.52 months and 36.44 ± 19.34 months respectively. The UDI-6, IIQ-7, POPDI-6, and PISQ-12
scores within each of the two age groups improved signiﬁcantly after surgery. Comparatively, the
POPDI-6 score was better whereas the PISQ-12 score was poorer among patients aged 75 years. Older
women had signiﬁcantly more preoperative comorbidities. The operative time, perioperative compli-
cations, and length of hospital stay showed no difference between the two groups. The intraoperative
blood loss was signiﬁcantly less in the older group and neither group had mortality.
Conclusion: This study showed that adequately optimized older patients undergoing pelvic organ pro-
lapse surgery experienced the same anatomical outcomes, comparable improved quality of life,
morbidity, and mortality as their counterparts of younger age.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Since 1950, the proportion of older persons (approximately 60
years old) has been rising steadily from 8% in 1950 to 11% in 2009
and it is expected to reach 22% (44 million) of the projected two
billion world population in 2050 [1]. Women usually live longerDepartment of Obstetrics and
inkou Medical Center, 5, Fu-
bstetrics & Gynecology. Publishedthan men and thus constitute the majority of the aged population
[1]. With better health care systems, more elderly women pre-
senting with at least one pelvic ﬂoor disorder would be found
among the increasing aging population. The proportion of women
reporting symptoms of pelvic ﬂoor disorder also increases with age,
from about 10% between the ages of 20 years and 39 years to almost
50% in those who are 80 years [2].
The changing demographic is likely to increase the demand for
pelvic ﬂoor surgery, an effective treatment option for pelvic organ
prolapse (POP). Furthermore, the reported lifetime risk of undergo-
ing a single operation for prolapse or incontinence by age 80 yearsby Elsevier Taiwan LLC. All rights reserved.
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tions especially with older persons. Available information on the
mortality andmorbidity following urogynecologic surgery in elderly
women is limited but known risks are higher regardless of comor-
bidity status [4]. The need to balance the risks and beneﬁts would
depend upon available information on the association between age
and surgical outcomes. Published data on the outcomes of surgery in
older patients are scarce and one study reported that a third of
original research papers excluded elderly people without justiﬁca-
tion [5]. The increase in life expectancy could have led to several
studies using age 75 years as the cut-off for reporting outcomes
[6e8]. Using such a similar cut-off age may allow for comparison.
Conventional surgical treatment for advance pelvic organ pro-
lapse has been performed via the abdominal or vaginal route.
Favorable long-term objective and subjective outcomes with
improved quality of life with vaginal sacrospinous ligament ﬁxa-
tion (SSF) surgery have been shown [9]. Moreover, concomitant
use of mesh for anterior vaginal wall repair may reduce risk of
recurrent cytocoele [10]. The objective of this study was to esti-
mate the association of age with outcomes of vaginal SSF and
anterioretransobturator mesh repair surgery for advanced pelvic
organ prolapse.
Materials and methods
The Institutional Review Board of Chang-Gung Memorial Hos-
pital, Taoyuan, Taiwan had approved the chart evaluation of this
study. As an arm of an initial pilot study [11], patients who were
referred to the urogynecology division of the outpatient center from
August 2006 to September 2011 for treatment of symptomatic
stages III and IV pelvic organ prolapse according to the International
Continence Society (ICS) grading system [12] were consecutively
enrolled. Patients included in the study were those with symp-
tomatic advanced pelvic organ prolapse and who had provided
informed consent for surgery. Patients deemed not medically ﬁt
after assessment by a medical physician for surgery would be
excluded from the study. Themethods are brieﬂy described here. All
included patients had initial preoperative assessment that
comprised a medical history, urine analysis, physical examination,
and pelvic examination. All patients were asked to complete a
72-hour voiding diary and subjective evaluation using theTable 1
Preoperative demographics of patients undergoing combined anterior transobturator me
Age 75 y (n ¼ 45)
Age (y) 77.67 ± 3.01 (76.75e78.60)
(range, 75e88)
Parity 5.51 ± 2.45 (4.76e6.27)
(range, 1e12)
Body mass index 24.96 ± 3.41 (23.91e26.01)
(range, 17.3e32.7)
Postmenopausal status 45 (100)
Hormone therapy 36 (80)
Systemic 0 (0)
Topical 36 (100)
Cardiovascular diseases 5 (11.1)
Coronary heart disease 1 (20)
Stroke 1 (20)
Cardiac dysrhythmias 3 (60)
Hypertension 29 (64.4)
Diabetes 9 (20)
Constipation 0
Smoking 0
Data are presented as n or mean ± standard deviation with 95% CI or 100th percentile w
a Unpaired t test.
b Chi-squared test.
c Fisher's exact test.Urogenital Distress Inventory (UDI-6) [13], Incontinence Impact
Questionnaire (IIQ-7) [14], Pelvic Organ Prolapse Distress Inventory
6 (POPDI-6) [15], and Pelvic Organ Prolapse/Urinary Incontinence
Sexual Questionnaire (PISQ-12) [16,17]. Objectively, this study
evaluated the Pelvic Organ Prolapse Quantiﬁcation (POP-Q) staging
[12] and performed a multichannel urodynamic and a 1-hour pad
test.
Patients with comorbidities such as diabetes mellitus, hyper-
tension, and constipation were treated and medical conditions
were addressed to the full extent prior to surgery in conjunction
with medical physicians and anesthetists. All patients were coun-
seled on the surgical procedure and informed of the potential
beneﬁts and complications following mesh surgery. The senior
author T.S.L operated on all the included patients, who were sub-
divided into two age groups: 75 years and <75 years.
Pelvic examinations were performed with the patients in semi-
supine lithotomy position and a split speculum technique was used
for evaluation. Examination ﬁndings were documented using the
nine-point description as suggested by the ICS [12]. Classiﬁcations of
prolapse followed the ICS ordinal stages of pelvic organ prolapse
(POP-Q) from0 to IV andwere deﬁned according to standards [12,18]
Multichannel urodynamic study included both ﬁlling and voiding
cystometry with surface electrode electromyography, urethral pres-
sure proﬁle measurement, and free uroﬂowmetry using an 8F
double-lumen urethral catheter. Prolapses were reduced with ring
pessarieswhenurodynamicevaluationswereperformed.Adiagnosis
of urodynamic stress incontinence (USI) was made on demonstrable
involuntary leakage of urine during increased abdominal pressure, in
the absence of detrusor contraction observed at ﬁlling cystometry.
Occult USI was deﬁned in patients who only leaked when the pro-
lapse had been repositioned. Bladder outlet obstruction was diag-
nosed according to the bladder outlet obstruction normogram for
women suggested by Blaivas and Groutz [19]. All datawere recorded
and analyzed using the Dantec Menuet (Dantec Medical A/S, Skov-
lunde, Denmark) and MMS Solar Gold (Medical Measurement Sys-
tem, Dover, NH, USA) multichannel urodynamic machines.
The choice of anesthesia was made according to patient and
surgeon preference. The surgeries performed in sequence, if indi-
cated, would be vaginal total hysterectomy, anterior vaginal mesh
procedure (Perigee procedure), SSF, posterior colporrhapy, and
mid-urethral tension-free sling. All patients had an advanced plansh repair and vaginal sacrospinous ligament ﬁxation according to age.
Age < 75 y (n ¼ 180) p
58.82 ± 9.09 (57.46e60.18) <0.001a
(range, 38e74)
3.59 ± 1.36 (3.39e3.80) <0.001a
(range, 1e 9)
24.87 ± 2.99 (24.42e25.32) 0.863a
(range, 18.0e35.2)
115 (63.9) <0.001b
95 (52.8) 0.001b
3 (3.2) 0.561c
92 (96.8) 0.281b
6 (3.3) 0.046c
1 (16.7) 0.727c
2 (33.3) 0.576c
3 (50) 0.608c
65 (36.1) 0.001b
24 (13.3) 0.258b
0
0
ithin parentheses.
Fig. 1. Time to prolapse. The cumulative objective and subjective cure rates for massive
prolapse were 93.0% and 95.3%, respectively for patients aged 75 years (median
follow-up 33.9 ± 18.5 months; 95% conﬁdence interval, 29.3e38.2; range 12e66
months). The cumulative objective and subjective cure rates for massive prolapse were
92.5% and 92.5%, respectively for patients aged <75 years (median follow-up
36.4 ± 19.3 months; 95% conﬁdence interval, 32.9e40.0; range 12e69 months;
p ¼ 0.401).
Table 2
Prior surgical procedure and surgical procedure according to age.
Age 75 y (n ¼ 45)
Prior pelvic surgery (n) 5
VTHþA-P 1
VTHþA-PþSS 1
TVT 1
TAH 2
Primary surgery (n)
SSþPerigeeþA-P 5
SSþPerigeeþA-Pþ
VTH
35
SSþPerigeeþA-Pþ
TOT/TVT
1
SSþPerigeeþA-Pþ
VTHþTOT/TVT
4
Secondary surgery (n) 0
MUS/TOT/Mini slings 0
OP time, (min) 72.12 ± 16.35 (67.08e77.15)
(range, 46 to 115)
Intra-OP 70.00 ± 42.65 (56.87e83.13)
Blood loss (mL) (range, 10e200)
Hemoglobin 1.12 ± 0.79 (e1.47 to 0.98)
Difference (g/dL) (range, 3.3 to 0.5
Hospital stay (d) 4.19 ± 0.45 (4.05e4.32)
(range, 4e6)
Complications, total 6 (17.1)
Complications, major
Organ injury 0
Complications, minor
Mesh exposure, vagina 1 (2.3)d
Infection 0
Hb difference > 2 (g/dL) 5 (14.3)
Anemia with transfusion 0
Other complications 0
Data are presented as mean ± standard deviation or 100th percentile within parenthese
A-P ¼ anterior and posterior colporrhaphy; Hb difference ¼ pre- and postoperat
complications ¼ cardiopulmonary, thromboembolic, central nervous system/neurologic
terectomy; TOT ¼ transobturator sling; TVT ¼ tension-free vaginal tape; VTH ¼ vaginal
a Unpaired t test.
b Chi-squared test.
c Fisher's exact test.
d IUGA/ICS Classiﬁcation of Complications: age 75 years: 2AaT3S1; age <75 years: 3A
1BT2S12.
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order described. The Perigee (American Medical Systems, Minne-
tonka, MN, USA) device designed for the anterior vaginal wall
defect was used as the mesh deployed at the anterior vaginal wall.
The anterior vaginal wall repair on all patients using the Perigee
was carried out as described by Rane et al [20]. Vaginal SSF using
the Miya hook technique as described by Miyazaki [21] was
adopted. Cystoscopic assessment for the integrity of the lower
urinary tract was performed at the end. All patients received pro-
phylactic antimicrobials (500 mg Cefazolin) prior to surgery and
continued every 6 hours for a day after surgery.
A Foley indwelling catheter and vaginal pack were placed for 72
hours. The bladder was scanned (BVI 3000; Diagnostic Ultrasound
Corp., Bothell, WA, USA) for postvoid residual every 4 hours after
removal of the urinary catheter. Sterile, intermittent catheterization
was performed whenever the postvoid residual volume exceeded
150 mL. Catheterization was stopped once the amount of postvoid
residual was consistently <20% of self-voided volume. Patients
were evaluated for urinary retention prior to discharge.
All postmenopausal women were offered either systemic or
local intravaginal estrogen replacement prior to and after surgery
unless it was contraindicated or the patient had refused. All pa-
tients were followed up at 1 week, 1 month, 3 months, 6 months, 1
year, and annually thereafter postsurgery. The surgeon, along with
the other authors, performed the postoperative POP-Q examina-
tion. If a patient was unable to participate in the follow-up, sheAge < 75 y (n ¼ 180) p
15 0.558b
3
2
1
9
23 0.495b
118 0.116b
6 0.577c
33 0.091c
3 0.510c
3 0.510c
72.02 ± 18.04 (69.32e74.72) 0.975a
(range, 29e123)
112.18 ± 109.25 (95.84e128.53) 0.014a
(range, 10e700)
1.36 ± 1.81 (e1.63 to 1.089) 0.631a
) (range, 4.0 to 0.6)
4.20 ± 0.59 (4.11e4.29)
(range, 4e7)
0.875a
34 (18.9) 0.155b
0
7 (4.0)d 0.501c
1 (0.5)d 0.800c
26 (14.4) 0.289c
0
0
s.
ive hemoglobin difference; MUS ¼ mid-urethra sling; OP ¼ operation; Other
complications; SS ¼ sacrospinous ligament ﬁxation; TAH ¼ total abdominal hys-
hysterectomy.
aT3S1, 3AaT4S1, 2AcT3S1, 2AaT3S1, 2AaT3S1, 3AbT3S1, 3AaT4S1 and one infection
Y.L. Tan et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 348e354 351would be contacted via telephone to establish the well-being status
annually postoperation.
The outcome measure was the objective cure rate, deﬁned as <
stage 2 prolapse at the anterior vaginal wall and all other com-
partments. Patients completed the IIQ-7, UDI-6, POPD1-6, and
PISQ-12 questionnaires postoperatively at the 1 year follow-up. No
or mild abdominal organ falling out sensation (Question 3) and no
or mild heaviness (Question 2) on the POPDI-6 were taken as
subjective success. Patients with pad weight >2 g or with demon-
strable urinary leakage on urethral pressure proﬁlometry (cough
proﬁle) were considered to have de novo USI and recurrent USI,
respectively.
Descriptive statistics was used for demographics and preoper-
ative data. Unpaired t test was employed for comparison of pre- and
postoperation continuous data. Fisher's exact test or Chi-square test
and McNemar's test were used for categorical data. Values of
p < 0.05 were considered statistically signiﬁcant for all compari-
sons. All statistical analysis were performed using the commercial
software SPSS version 11 (SPSS Inc., Chicago, IL, USA).Results
A total of 225 patients who had undergone prolapse surgery
were recruited into this study. Of the patients recruited, 80% were
aged <75 years and 20% were aged 75 years. The demographics
are shown in Table 1. Older women had signiﬁcantly more
comorbidities.
Postoperative data of 217 patients were available. The elderly
group had a mean follow-up of 33.93 ± 18.52 months and the
younger group had a mean follow-up of 36.44 ± 19.34 months
(p ¼ 0.401). Eight patients were unable to continue with scheduledTable 3
Pelvic organ prolapse quantiﬁcation measurement preoperatively and at postoperative f
Age 75 y (n ¼ 43)
Pre Post
Aa 2.05 ± 0.94 (1.76e2.34)
(range, 0e3) 2.70 ± 0.45 (2.85e2.57)
(range, 3e2)
Ba 6.13 ± 2.22 (5.44e6.81)
(range, 4e11) 2.76 ± 0.54 (2.92e2.59)
(range, 3e1.5)
C 6.44 ± 2.83 (5.57e7.31)
(range, 3e12) 8.24 ± 0.91 (8.52e2.76)
(range, 10e6)
Ap 1.33 ± 1.19 (0.96e1.69)
(range, 1e13) 2.76 ± 0.23 (2.83e2.69)
(range, 3e1.5)
Bp 5.34 ± 2.76 (4.49e6.19)
(range, 3e11) 2.72 ± 0.80 (2.97e2.47)
(range, 3e4)
D 5.26 ± 2.76 (4.36e6.15)
n ¼ 39 (range, 1e10) 8.50 ± 0.71 (14.85e0.15)
n ¼ 2 (range, 8e10)
TVL 9.37 ± 1.13 (9.02e9.72)
(range, 7e13) 8.41 ± 1.14 (8.07e8.77)
(range, 7e12)
Gh 5.63 ± 1.20 (5.26e6.00)
(range, 4e8) 5.24 ± 0.65 (5.04e5.44)
(range, 4e6)
Pb 2.74 ± 1.80 (2.41e3.08)
(range, 0.5e4.5) 3.03 ± 0.77 (2.80e3.27)
(range, 2e5)
Data are presented as mean ± standard deviation with 95% CI in parentheses.
Aa ¼ anterior wall 3 cm from hymen; Ap ¼ posterior wall 3 cm from hymen; Ba ¼ anter
C ¼ cervix or vaginal cuff (cm); D ¼ posterior fornix (if cervix is present) (cm); Gh ¼ genit
anus (cm); TVL ¼ total vaginal length (cm).
a Unpaired t test.follow-up because of personal reasons. The cumulative objective
cure rates were 93.0% and 92.5% for patients aged 75 years and
<75 years, respectively. There were no signiﬁcant differences
(p ¼ 0.509) and the same was observed for cumulative subjective
cure rates, which were 95.3% and 92.5%, respectively (p ¼ 0.521;
Fig. 1).
Surgeries performed are shown in Table 2. Although the intra-
operative blood loss was signiﬁcantly less with patients who were
older, difference in haemoglobin levels of the two groups did not
show any statistical signiﬁcance. Moreover, no patients required
any blood transfusion. The lengths of hospital staywere similar. The
total mesh exposure rate was 3.69% (8/217). Only one infection
occurred after surgery in the younger age group and there was no
further sequelae after treatment with antibiotics. There were no
major organ injury or documented mortality.
In this study, POP-Q measurements prior to and after surgery
did not showany signiﬁcant differences for both groups (Table 3). In
total, 17 patients did not have concurrent hysterectomy. Table 4
shows the effect of surgery on UDI-6, IIQ-7, POPDI-6, and PISQ-12
scores. Within each age group, all the scores improved signiﬁ-
cantly after surgery. Only the PISQ-12 recorded markedly poorer
scores for those aged75 years prior to and after surgery when the
two groups were compared. By contrast, only the POPDI-6 recorded
signiﬁcantly better scores after surgery. The urodynamics data are
represented in Table 5.Discussion
Our study showed that patients who were aged 75 years with
advance POP and underwent comprehensive vaginal reconstruction
surgery had comparable surgical anatomical outcomes and qualityollow-up according to age.
Age < 75 y (n ¼ 174) pa
Pre Post
1.99 ± 0.96 (1.84e2.13) 0.725
(range, 0.5e3) 2.86 ± 0.33 (2.91e2.81) 0.057
(range, 3e2)
6.60 ± 2.19 (6.27e6.93) 0.210
(range, 4e11) 2.81 ± 0.68 (2.91e2.71) 0.644
(range,3e1.5)
6.56 ± 2.66 (6.16e6.96) 0.702
(range, 3e12) 7.94 ± 1.02 (8.09e7.79) 0.076
(range, 12e6)
1.39 ± 1.30 (1.19e1.58) 0.785
(range, 1e3) 2.75 ± 0.21 (2.88e2.72) 0.697
(range, 3e1.5)
5.02 ± 2.51 (4.64e5.39) 0.464
(range, 3e11) 2.30 ± 1.57 (2.53e2.06) 0.090
(range, 3e4)
5.62 ± 2.66 (5.20e6.03) 0.454
n ¼ 160 (range, 2e11) 7.80 ± 0.77 (8.23e7.37
n ¼ 15 (range, 8e11)
9.01 ± 1.15 (8.84e9.18) 0.067
(range, 6e14) 8.14 ± 1.14 (7.97e8.31) 0.150
(range, 6e13)
5.52 ± 0.85 (5.40e5.65) 0.507
(range, 4e9) 5.26 ± 0.67 (5.16e5.36) 0.859
(range, 4e6)
2.75 ± 1.24 (2.56e2.94) 0.978
(range, 0e5) 3.02 ± 0.87 (21.90e3.16) 0.950
(range, 1e4.5)
ior wall, most dependent par (cm); Bp ¼ posterior wall, most dependent par (cm);
al hiatus, meatus to fourchette (cm); Pb ¼ perineal body, posterior fourchette to mid
Table 4
The UDI-6, IIQ-7, POPDI-6, and PISQ-12 scores pre- and postsurgery.
Age 75 y (n ¼ 43) Age < 75 y (n ¼ 174) p (between groups)a
UDIe6 Pre 14.49 ± 3.81 (13.32e15.66) 14.37 ± 4.10 (13.75e14.98) 8.861
Post 9.30 ± 3.15 (8.33e10.27) 9.48 ± 2.78 (9.07e9.90) 0.711
p (within groups) <0.001b <0.001b
IIQe7 Pre 12.98 ± 5.44 (11.30e14.65) 12.66 ± 5.71 (11.80e13.52) 0.743
Post 8.70 ± 3.97 (7.47e9.92) 8.49 ± 4.52 (7.82e9.17) 0.787
p (within groups) <0.001b <0.001b
POPDIe6 Pre 15.05 ± 2.79 (14.19e15.91) 15.00 ± 3.37 (14.50e15.50) 0.933
Post 9.35 ± 3.04 (8.41e10.28) 10.63 ± 2.64 (10.24e11.03) 0.006
p (within groups) <0.001b <0.001b
PISQe12 Pre 17.80 ± 6.36 (13.25e22.35) 23.05 ± 5.88 (21.80e24.29) 0.009
n ¼ 10 (25%) n ¼ 88 (50.6%)
Post 22.50 ± 5.84 (18.33e26.67) 27.94 ± 5.84 (26.71e29.18) 0.006
n ¼ 10 (25%) n ¼ 88 (50.6%)
p (within groups) 0.024b <0.001b
PISQe12eQ1 Pre 1.40 ± 1.08 (0.63e2.17) 1.75 ± 0.78 (1.58e1.91) 0.198
Post 1.30 ± 0.67 (0.82e1.78) 2.02 ± 0.98 (1.81e2.23) 0.026
p (within groups) 0.726 0.037
PISQe12eQ 2 Pre 1.20 ± 1.23 (0.32e2.08) 1.56 ± 0.58 (1.43e1.68) 0.115
Post 1.70 ± 0.95 (1.02e2.38) 2.01 ± 0.65 (1.87e2.15) 0.027
p (within groups) 0.096 <0.001
PISQe12eQ 3 Pre 1.20 ± 0.92 (0.54e1.86) 1.47 ± 0.52 (1.35e1.58) 0.167
Post 1.60 ± 0.70 (1.10e2.10) 2.08 ± 0.48 (1.98e2.18) 0.006
p (within groups) 0.104 <0.001
PISQe12eQ 4 Pre 1.10 ± 0.74 (0.57e1.63) 1.27 ± 0.54 (1.16e1.39) 0.360
Post 2.00 ± 0.94 (1.32e2.67) 2.01 ± 0.50 (1.89e2.11) 0.891
p (within groups) 0.041 <0.001
PISQe12eQ 5 Pre 2.10 ± 0.74 (157e2.63) 2.23 ± 0.83 (2.05e2.40) 0.642
Post 2.10 ± 0.86 (1.47e2.73) 2.45 ± 0.92 (2.25e2.65) 0.249
p (within groups) 1.000 0.084
PISQe12eQ 6 Pre 1.40 ± 0.97 (0.71e2.09) 2.17 ± 1.13 (1.93e2.41) 0.041
Post 1.60 ± 0.52 (1.23e1.97) 2.18 ± 0.90 (1.99e2.37) 0.049
p (within groups) 0.555 0.935
PISQe12eQ 7 Pre 1.50 ± 1.27 (0.59e2.41) 1.58 ± 0.96 (1.38e1.78) 0.810
Post 1.50 ± 0.71 (0.98e2.01) 1.78 ± 0.82 (1.61e1.96) 0.297
p (within groups) 1.000 0.151
PISQe12eQ 8 Pre 1.30 ± 0.48 (0.95e1.65) 1.57 ± 0.67 (1.43e1.71) 0.226
Post 2.60 ± 1.26 (1.69e3.50) 2.99 ± 0.86 (2.81e3.17) 0.203
p (within groups) 0.009 <0.001
PISQe12eQ 9 Pre 1.70 ± 0.82 (1.11e2.29) 2.58 ± 0.69 (2.43e2.73) <0.001
Post 2.00 ± 0.82 (1.41e2.58) 2.90 ± 0.58 (2.78e3.03) <0.001
p (within groups) 0.081 <0.001
PISQe12eQ 10 Pre 2.00 ± 067 (1.52e2.48) 2.68 ± 0.65 (2.54e2.82) 0.002
Post 2.30 ± 0.67 (1.81e2.78) 2.77 ± 0.60 (2.64e2.90) 0.022
p (within groups) 0.081 0.219
PISQe12eQ 11 Pre 1.80 ± 0.92 (114e2.46) 2.35 ± 0.99 (2.14e2.56) 0.097
Post 2.00 ± 0.82 (1.41e2.58) 2.60 ± 0.74 (2.44e2.76) 0.017
p (within groups) 0.304 0.068
PISQe12eQ 12 Pre 1.00 ± 0.67 (0.52e1.48) 1.65 ± 0.64 (1.51e1.78) 0.003
Post 1.70 ± 0.82 (1.11e2.29) 2.08 ± 0.41 (1.99e2.17) 0.016
p (within groups) 0.066 <0.001
Data are presented as mean ± standard deviation with 95% conﬁdence interval in parentheses.
IIQ-7 ¼ Incontinence Impact Questionnaire (score 0e21); PISQ-12 ¼ Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (score 0e48); POPDI-6 ¼ Pelvic Organ
Prolapse Distress Inventory 6 (score 0e24); UDI-6 ¼ Urinary Distress Inventory (score 0e18).
a Unpaired t test.
b Paired t test.
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by Gerten et al [22] reported that both subjective and objective
anatomical and quality-of-life outcomes were expected to be
similar for both older and younger patients with a heterogeneous
approach to prolapse surgery. Another study had shown compara-
ble outcomes between octogenarians and younger patients after
transvaginal prolapse surgery [23]. Moreover, there was also sig-
niﬁcant improvement in the quality-of-life measures for their older
patients who on average were much older than the cohort group in
this study. By contrast, cadaveric fascia and levator myorrhapy were
used in their study as comparedwith synthetic mesh and SSF in this
study, respectively. The anatomical success rate of up to 5 years was
reported to be 94.3% for the Perigee system [24] whereas others
have reported short-term success ranging from 84.2% to 93.0%[25e28], which is comparable with the current ﬁndings. In view of
the available evidence, Sung et al [4] reported that women aged
between 60 years and 79 years did not have an increased risk of
complications compared with those aged below 60 years. In addi-
tion, the risk for having a perioperative complication was 1.23 if the
age of the patient was 70e79 years old. Stepp et al [6] in their
retrospective review had taken age 75 years as a cut-off for their
inclusion criteria. Mohammed et al [8] also used the cut-off age of
75 years when reporting their experiencewith pelvic reconstructive
surgery with transobturator mesh implants in 32 elderly women.
Ghezzi et al [7] reported their single-center experience with sur-
gical treatment for pelvic ﬂoor disorders of 138 women who were
aged 75 years. Hence, it would be appropriate to use 75 years as
the cut-off age to enable a possible comparison of results.
Table 5
Urodynamic data pre- and postoperatively.
Urodynamic
Age 75 y (n ¼ 43) Age < 75 y (n ¼ 174) p p
Pre Post Pre Post
n ¼ 43 n ¼ 43 n ¼ 174 n ¼ 174 (between groups,
preoperation)
(between groups,
postoperation)
USI (overt & occult) 5 (11.6) 9 (20.9) 59 (33.9) 16 (9.2) 0.005b 0.031c
p (within groups)a 0.424 <0.001
DO 7 (16.3) 1 (2.3) 7 (4.0) 4 (2.3) 0.003c 0.672b
p (within groups)a 0.070 1.000
DO with incompetent urethral
closure mechanism
4 (9.3) 2 (4.7) 6 (3.4) 1 (5.7) 0.676c 0.121c
p (within groups)a 0.625 0.039
BOO 28 (65.1) 1 (2.3) 61 (35.0) 1 (0.6) <0.001b 0.802b
p (within groups)a <0.001 <0.001
Detrusor underactivity 2 (4.7) 2 (4.7) 5 (2.9) 3 (1.7) 0.627b 0.258b
p (within groups)a 1.000 0.453
Data are presented as n (%).
BOO ¼ bladder outﬂow obstruction; DO ¼ detrusor overactivity; USI ¼ urodynamic stress incontinence.
a McNemar's test, within groups.
b Fisher's exact test.
c Chi-squared test.
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whilst this was noted only in 25% (10/40) of the older group. Barber
et al [29] had reported a similar proportion in patients with a mean
age of 75 years. Overall improvement in PISQ-12 score was seen
after surgery in this study. In a recent review, evidence suggests
that SSF technique offered a durable apical suspension without
compromising sexual function with dyspareunia rates of 3e7%
postprocedure [9]. Usage of mesh on both anterior and posterior
compartments has led to the reduction of sexual quality through
changes of vaginal dimensions and effects of scarring [30]. This
study utilized only anterior transobturator mesh for preventing the
recurrence of cystocoele. The judicious use of mesh may have
reduced the scarring and distortion of vagina cavity, possibly
resulting in improved sexual function. Up to 5 years, 40.9% of pa-
tients had reported improvement in sexual function and only 4.1%
had worsening dyspareunia whilst 45.1% reported no sexual
dysfunction [24]. Studies have also shown that vaginal mesh does
not have a negative impact on sexual function and no signiﬁcant
difference in rates of dyspareunia when compared with traditional
repairs in the anterior compartment [28]. Sexual function is com-
plex and multifactorial; and although an improvement in the PISQ
score was demonstrated, this cannot be recognized as the main
contributory factor. The relatively poorer score in the older group,
however, needs further evaluation and study.
There were no differences in operative time between the groups
studied and the duration was considered short, in view of the
complexity of the surgical procedure performed. Operative time
has been shown to be an independent predictor of perioperative
complications [6]. The shorter operative time observed in this study
could have led to signiﬁcantly less blood loss among the elderly and
reduction in perioperative complications. There was also no dif-
ference in perioperative complications between the groups. The
mesh exposure rate was 3.56% and considered low. The rate of
exposure after undergoing Perigee at and beyond 1 year has been
reported to range from 5% to 11% [24e28] but adverse events did
continue and differed by groups.
In this study, the older patients had higher incidence of preex-
isting medical comorbidities, which potentially increased the risk
of surgery. With proper evaluation and the involvement of other
specialists, including medical physicians and anesthetists, to
improve the overall well-being and treat underlying medical con-
ditions, possible surgical risks may reduce. Preexisting medical
comorbidity is the most accurate predictor of postoperativeoutcomes in older women undergoing surgery [22]; and, with that
in mind, all patients in this study had their associated medical
conditions treated and health optimized prior to surgery. The pa-
tients were hence carefully assessed, treated where necessary and
considered sufﬁciently healthy for undergoing elective surgery.
This may represent a healthier cohort of patients compared with
the general population and interpretation of the results must be
made accordingly. None of the patients experienced any major
intraoperative complications, as evidenced by the short in-hospital
staywith amean of 4.19± 0.45 days and 4.20± 0.59 days for the age
75 years and <75 years groups, respectively.
The present studyalso showed lowmorbidity andmortality rates
with prolapse surgery among the elderly, suggesting that surgery
can be safely offered to these patients. It is thus concluded that age
alone should not be seen as an obstacle for prolapse surgery as a
treatment option. Similarly, Stepp et al [6] did notﬁnd an association
between age alone and morbidity rates of urogynecology surgeries.
Previous studies have also reported various pelvic surgeries with
low morbidity among older patients [6,7]. The difference, however,
was that SSF was used for vaginal vault suspension in this study,
whereas McCall culdoplasty or ileococcygeus ﬁxation was per-
formed in prior research. Moreover, only outcomes in elderly
womenwere analyzed and the studywas limited by the absence of a
younger control group. By contrast, one study did report higher
mortality andmorbidity in elderlywomen following urogynecologic
surgeries, although the absolute risk of death was low [4]. In addi-
tion, it was suggested that obliterative procedures were associated
with lower proportion of adverse perioperative outcomes, as
compared with reconstructive procedures with or without hyster-
ectomy. Nevertheless, this comparison was not evaluated in this
study as the preference was for reconstructive surgery.
This investigation was not a randomized control study and the
results represent a cohort of patients that cannot be generalized to
all. Moreover, the patients were recruited from a considerably
healthier cohort and all surgeries were performed by a single
surgeon in a single center, which may be subjected to bias.
Although no difference in outcome was noted between the two
groups, the available sample size was small and unable to achieve
adequate statistical power. Despite such limitations, this investi-
gation did provide additional information and may serve as the
basis for further investigations possibly conducted in more than
one center. The strengths of this study include reporting in both
objective and subjective cure rates, reasonable anatomical
Y.L. Tan et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 348e354354outcomes, outcomes categorized in different compartments, and a
relatively long follow-up duration. Included in this study was a
control group of younger patients. The questionnaires used were
also well validated.
This investigation is one of the few studies that has examined
the association of age with the outcomes of transvaginal prolapse
surgery utilizing the SSF procedure coupled with anterior mesh
repair for prevention of cystocoele recurrence. Adding this infor-
mation to the limited available knowledge allows an improved
counseling for elderly patients who desire surgical treatment. With
the trend of increasing life expectancy, it may be necessary to
reconsider age as a major limitation for surgical treatment and also
to take quality of life into consideration. Adequately optimized aged
patients undergoing pelvic organ prolapse surgery can experience
the same surgical outcomes and comparable expected quality of life
as their counterparts of younger age.Conﬂicts of interest
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